Cipla Ltd Pharmaceuticals LARGECAP Current Price ₹ 1,506.60 1.07% 3Y CAGR 17.43% High Volatility Live Performance vs Equity Large Cap 1m6m1y3ymax Current value of ₹ 100 invested once 3 years ago would be Cipla Ltd ₹ 164.35 Equity Large Cap ₹ 143.15 2022AprJulOct2023AprJulOct2024...
Products and brands offered by the company include Scrap, Export Incentives, Sale of services and Pharmaceuticals. Read more AUROPHARMA Shares FAQs What is the total asset value of Aurobindo Pharma Ltd.? What is the current share price of Aurobindo Pharma Ltd.? What is the market cap of ...
The globalgeneric pharmaceuticals marketwas valued at USD 361.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. The growth can be attributed to the number of ANDA approvals and launches of generic drugs products is increasing const...
Branded generics dominate the pharmaceuticals market, constituting nearly 70 to 80 per cent of the market. Four company's five years stock prices were selected for the study under nifty. Dr. Reddys Lab, Cipla Ltd, Ranbaxy Laboratories, and Sun Pharma. The main objective of this study is to ...
Bayer AG, Lilly, GlaxoSmithKline PLC, Petros Pharmaceuticals, Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd, Lupin Limited, Futura Medical, Cure Pharmaceutical, 23andMe, Hims & Hers Health, Inc., RO, BlueChew, GoodRx, Inc. Customization scope Free report customization (equivalent up to...
F. Hoffmann-La Roche Ltd., NATCO Pharma Limited, Teva Pharmaceutical Industries Ltd, LUPIN Limited, Amneal pharmaceuticals LLC, Zydus Cadila, Sun Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, Mylan N.V., and Hetero Group are the prominent Tamiflu (Oseltamivir Phosphate) market manuf...
Pharmaceuticals Other Plant Protein-based Applications Insect Protein-based Applications Food & Beverage Processed Whole Insects Processed Insect Powder Insect Protein Bars & Shakes Insect Baked Products & Snacks Insect Confectioneries Insect Beverages ...
|| ShareSansar || No. 1 online financial portal of Nepal that provides a complete information of share market , Today's Share Price, Floor-sheet, Indices, Dividend, AGM, Book closure, Bonus,IPO, FPO, Right Share, Cash, Updated, Mutual fund, IPO, Com
The Glioblastoma Multiforme Treatment Market is expected to reach USD 3.02 billion in 2025 and grow at a CAGR of 8% to reach USD 4.44 billion by 2030. Arbor Pharmaceuticals, LLC, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sun Pharmaceutical Industries L
The Cyclosporine Drugs Market is growing at a CAGR of 4.1% over the next 5 years. AbbVie Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and Santen Pharmaceutical Co., Ltd. are the major companies operating in t